Delivery Order SPE2DR25D2101-SPE2DR26F47TK
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 7, 2026, for Lidocaine 5% Patch 30s with a ceiling value of $5,336.70. This firm fixed-price delivery order is not set aside and is scheduled for ultimate completion by January 8, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $38,387.34 for Lidocaine 5% patches (30-count units) by the Defense Logistics Agency on December 31, 2025. The contract is non-competitive and structured as a firm fixed-price delivery order with an ultimate completion date of January 2, 2026. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $5,131.45. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and was competitively awarded without any set-aside designation. The award falls under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, for the supply of Lidocaine 5% Patch in a quantity of 30 units. This is a firm fixed price contract with a ceiling value of $5,710.63 and an ultimate completion date of July 22, 2025. The award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,319.05 by the Defense Logistics Agency on January 20, 2026, for Lidocaine 5% patches (30-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 21, 2026, and represents a task order executed under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order by the Defense Logistics Agency on September 5, 2025, for the supply of Lidocaine 5% Patch 30-count units. This firm fixed-price contract carries a ceiling value of $8,709.12 and is scheduled for completion by September 8, 2025. The award was made without a set-aside designation, indicating it was competed among qualified vendors in the open...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order by the Defense Logistics Agency for Lidocaine 5% Patch 30s on July 8, 2025. The delivery order, valued at $4,520.16, represents a competitive award with no set-aside designation and an ultimate completion date of July 9, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Lidocaine 5% patches in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $10,866.10 and an ultimate completion date of August 29, 2025. The contract carries no set-aside designation and was awarded competitively. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 4, 2025, for Lidocaine 5% Patch 30s with a ceiling value of $6,016.01. The contract is a firm fixed-price delivery order with an ultimate completion date of December 5, 2025, and carries no set-aside designation. This award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,361.04 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Lidocaine 5% Patch 30s. The contract employs firm fixed-price pricing with a completion deadline of August 18, 2025, and was awarded through open competition with no set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F47TKDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 27, 2026, for Lidocaine 5% Patch 30s with a ceiling value of $2,285.28. This firm fixed-price delivery order, with an ultimate completion date of January 28, 2026, represents a competitive award with no set-aside designation. The contract is executed under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. This delivery order exemplifies the Defense Logistics Agency's reliance on AmerisourceBergen's extensive pharmaceutical supply network to meet critical medical procurement needs across the Department of Defense healthcare system. The Lidocaine patch represents pain management commodities that support military treatment facilities and veteran healthcare programs. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in fulfilling diverse pharmaceutical requirements through competitive procurement, with delivery orders ranging from modest values to substantial medical supply commitments, positioning the company as a critical vendor for federal military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 1/26/26 |